Reference Hub3
Transition to ISO 15189 : 2012 for Cytopathology Laboratories Part 1: General and Management Requirements

Transition to ISO 15189 : 2012 for Cytopathology Laboratories Part 1: General and Management Requirements

Eleftherios Vavoulidis, Stavros Archondakis, Maria Nasioutziki, Ourania Oustambasidou, Angelos Daniilidis, Konstantinos Dinas, Aristotelis Loufopoulos
Copyright: © 2016 |Volume: 5 |Issue: 3 |Pages: 21
ISSN: 2160-9551|EISSN: 2160-956X|EISBN13: 9781466693425|DOI: 10.4018/IJRQEH.2016070101
Cite Article Cite Article

MLA

Vavoulidis, Eleftherios, et al. "Transition to ISO 15189 : 2012 for Cytopathology Laboratories Part 1: General and Management Requirements." IJRQEH vol.5, no.3 2016: pp.1-21. http://doi.org/10.4018/IJRQEH.2016070101

APA

Vavoulidis, E., Archondakis, S., Nasioutziki, M., Oustambasidou, O., Daniilidis, A., Dinas, K., & Loufopoulos, A. (2016). Transition to ISO 15189 : 2012 for Cytopathology Laboratories Part 1: General and Management Requirements. International Journal of Reliable and Quality E-Healthcare (IJRQEH), 5(3), 1-21. http://doi.org/10.4018/IJRQEH.2016070101

Chicago

Vavoulidis, Eleftherios, et al. "Transition to ISO 15189 : 2012 for Cytopathology Laboratories Part 1: General and Management Requirements," International Journal of Reliable and Quality E-Healthcare (IJRQEH) 5, no.3: 1-21. http://doi.org/10.4018/IJRQEH.2016070101

Export Reference

Mendeley
Favorite Full-Issue Download

Abstract

Nowadays, due to the latest advances in Laboratory Medicine, diagnostic medical laboratories with their highly qualified personnel and state-of-the-art analytical equipment, have completely changed the way modern healthcare is offered. In order to maintain or even increase the already high quality level of the provided testing services, diagnostic laboratories including the cytopathology ones, need to design and apply a Quality Management System (QMS) in agreement with the requirements of the ISO 15189 International Standard. The authors present their experience on the implementation of such a QMS in cytopathology laboratories and highlight the most important general and management parameters that should be taken into consideration when moving from ISO 15189:2007 to the latest ISO 15189:2012. In addition, useful recommendations and suggestions that could make the transition to the latest Standard easier are included. Finally, possible issues and potential adverse events associated with the laboratory's implementation of the ISO 15189:2012 are also described.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.